MarketCap
Nature's Sunshine Products NATR
$ 20.4
-0.58%
Facebook
X
Telegram
Nature's Sunshine Products Balance Sheet 2025-2008 | NATR
Brief overview of Nature's Sunshine Products's financial position
This overview follows the five latest available annual observations between 2021 and 2025.
Assets shifted from $258.9 million to $261.1 million, leaving five-period growth close to stagnation.
Assets and liabilities changed at similar rates, +0.9% and +2.2%. The funding mix did not shift sharply.
The equity-to-assets ratio is 61.9%, compared with 62.3% five periods ago. The balance sheet has a substantial internal cushion.
Negative net debt of -$75 million means cash holdings are larger than debt obligations.
Cash accounts for 36% of assets versus 33.3% initially. The change indicates the degree of financial flexibility.
Retained earnings reached $76.9 million, changing +119.6% over the period. A positive accumulated result supports equity.
What the balance sheet shows
Nature's Sunshine Products shows a high-quality balance sheet profile, with adequate internal capital and room for maneuver.
Annual Balance Sheet Nature's Sunshine Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-75 M | -70.5 M | -67.4 M | -42 M | -65.9 M | -87.1 M | -27 M | -49.1 M | -29.2 M | -22.4 M | -38.7 M | -58.7 M | -65 M | -73.6 M | -49.8 M | - | - | - |
Long Term Debt |
15.6 M | 10.3 M | 10.4 M | 13.7 M | 1.17 M | 2.42 M | - | - | 13.2 M | - | - | - | 10 M | 2.27 M | 5.89 M | - | - | - |
Long Term Debt Current |
3.27 M | 3.93 M | 4.55 M | 4.27 M | 4.35 M | 4.99 M | 4.94 M | - | - | 9.92 M | 2.7 M | - | 2.27 M | 3.35 M | 3.3 M | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 22.6 M | 25.7 M | 5.76 M | 21.8 M | 10.1 M | 11.1 M | 9.93 M | 25.8 M | 16.9 M | 20.6 M | 25.9 M | - | - |
Total Current Liabilities |
78.5 M | 65.7 M | 76.8 M | 65.6 M | 76.7 M | 69.7 M | 57.9 M | 66.7 M | 53.7 M | 63 M | 53.1 M | 57.9 M | 68.6 M | 61.4 M | 67.8 M | 65.2 M | - | - |
Total Liabilities |
99.6 M | 79.9 M | 90.2 M | 82.7 M | 97.5 M | 92.3 M | 83.6 M | 72.4 M | 75.5 M | 73.2 M | 64.3 M | 67.8 M | 94.4 M | 78.3 M | 88.4 M | - | - | - |
Deferred Revenue |
5.84 M | 2.77 M | 1.79 M | 2.26 M | 3.69 M | 2.09 M | 1.27 M | 1.2 M | 3.35 M | 3.67 M | 4.16 M | 4.72 M | 4.17 M | 4.31 M | 2.6 M | 3.38 M | - | - |
Retained Earnings |
76.9 M | 57.4 M | 49.7 M | 34.6 M | 35 M | 26 M | 4.69 M | -2.07 M | -2.07 M | 12.7 M | 18.1 M | 10.9 M | 36.1 M | 48.9 M | 25.9 M | 8.28 M | - | - |
Total Assets |
261 M | 241 M | 250 M | 230 M | 259 M | 249 M | 213 M | 193 M | 195 M | 206 M | 201 M | 197 M | 200 M | 194 M | 176 M | 159 M | - | - |
Cash and Cash Equivalents |
93.9 M | 84.7 M | 82.4 M | 60 M | 86.2 M | 92.1 M | 53.6 M | 50.6 M | 42.9 M | 32.3 M | 41.4 M | 58.7 M | 77.2 M | 79.2 M | 59 M | 47.6 M | 35.5 M | 34.9 M |
Book Value |
162 M | 161 M | 160 M | 147 M | 161 M | 157 M | 129 M | 121 M | 120 M | 132 M | 136 M | 129 M | 105 M | 116 M | 87.4 M | 159 M | - | - |
Total Shareholders Equity |
162 M | 161 M | 160 M | 147 M | 161 M | 157 M | 129 M | 121 M | 120 M | 132 M | 136 M | 129 M | 105 M | 116 M | 87.4 M | 68.4 M | 57.1 M | 53.7 M |
All numbers in USD currency
Quarterly Balance Sheet Nature's Sunshine Products
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
18.1 M | 9.69 M | 11 M | 10.6 M | 10.3 M | 11.2 M | 11.4 M | 2.11 M | 10.4 M | 11.3 M | 12.5 M | 13.4 M | 13.7 M | 14.5 M | 15.9 M | 16.5 M | 15.9 M | 16.5 M | 15.4 M | 15.6 M | 2.42 M | 16.4 M | 16.4 M | 16.4 M | - | 20.2 M | 20.2 M | 20.2 M | - | 1.84 M | 7.21 M | - | 13.2 M | - | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | 10 M | 10 M | 10 M | 10 M | 10 M | 10 M | 2.27 M | 2.27 M | 2.27 M | 2.27 M | 5.89 M | 5.89 M | 5.89 M | 5.89 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.8 M | 25.8 M | 25.1 M | 15.5 M | 16.3 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M |
Total Liabilities |
94.5 M | 98.1 M | 91.2 M | 85.6 M | 79.9 M | 82.7 M | 79.4 M | 87.6 M | 90.2 M | 87.9 M | 86.8 M | 87.9 M | 82.7 M | 81.8 M | 88.6 M | 88.9 M | 97.5 M | 92.1 M | 86 M | 104 M | 92.3 M | 92.3 M | 92.3 M | 92.3 M | 83.6 M | 83.6 M | 83.6 M | 83.6 M | 72.4 M | 72.4 M | 72.4 M | 72.4 M | 75.5 M | 75.5 M | 75.5 M | 75.5 M | 73.2 M | 73.2 M | 73.2 M | 73.2 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M | 67.8 M | 67.8 M | 67.8 M | 67.8 M | 94.4 M | 94.4 M | 94.4 M | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.78 M | 7.54 M | 5.5 M | 2.49 M | 2.77 M | 1.75 M | 2.22 M | 1.88 M | 1.79 M | 1.34 M | 1.43 M | 1.13 M | 2.26 M | 1.46 M | 1.83 M | 2.04 M | 3.69 M | 1.51 M | 1.97 M | 1.67 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 1.27 M | 1.27 M | 1.27 M | 1.27 M | 1.2 M | 1.2 M | 1.2 M | 2.28 M | 3.35 M | 4.79 M | 5.26 M | 3.96 M | 3.67 M | 3.67 M | 3.67 M | 3.67 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 4.72 M | 4.72 M | 4.72 M | 4.72 M | 4.17 M | 4.17 M | 4.17 M | 4.17 M | 4.31 M | 4.31 M | 4.31 M | 4.31 M | 2.6 M | 2.6 M | 2.6 M | 2.6 M |
Retained Earnings |
82 M | 72.8 M | 67.5 M | 62.2 M | 57.4 M | 57.7 M | 53.4 M | 52 M | 49.7 M | 40.7 M | 37.9 M | 35.5 M | 34.6 M | 32.7 M | 32.6 M | 32.1 M | 35 M | 21.6 M | 16.7 M | 10.2 M | 26 M | 26 M | 26 M | 26 M | 4.69 M | 4.69 M | 4.69 M | 4.69 M | -2.07 M | -2.07 M | -2.07 M | -2.07 M | -2.07 M | -2.07 M | -2.07 M | -2.07 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 36.1 M | 36.1 M | 36.1 M | 36.1 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M |
Total Assets |
261 M | 265 M | 255 M | 253 M | 241 M | 245 M | 236 M | 247 M | 250 M | 240 M | 236 M | 235 M | 230 M | 224 M | 233 M | 239 M | 259 M | 240 M | 233 M | 246 M | 249 M | 249 M | 249 M | 249 M | 213 M | 213 M | 213 M | 213 M | 193 M | 193 M | 193 M | 193 M | 195 M | 195 M | 195 M | 195 M | 206 M | 206 M | 206 M | 206 M | 201 M | 201 M | 201 M | 201 M | 197 M | 197 M | 197 M | 197 M | 200 M | 200 M | 200 M | 200 M | 194 M | 194 M | 194 M | 194 M | 176 M | 176 M | 176 M | 176 M |
Cash and Cash Equivalents |
87.6 M | 95.6 M | 81.3 M | 86.5 M | 84.7 M | 78.7 M | 68.7 M | 77.8 M | 82.4 M | 76 M | 69 M | 65.7 M | 60 M | 57 M | 56.3 M | 66.5 M | 86.2 M | 75.5 M | 74.9 M | 91.3 M | 92.1 M | 92.1 M | 92.1 M | 92.1 M | 53.6 M | 53.6 M | 53.6 M | 53.6 M | 50.6 M | 50.6 M | 50.6 M | 50.6 M | 42.9 M | 42.9 M | 42.9 M | 42.9 M | 32.3 M | 32.3 M | 32.3 M | 32.3 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 58.7 M | 58.7 M | 58.7 M | 58.7 M | 77.2 M | 77.2 M | 77.2 M | 77.2 M | 79.2 M | 79.2 M | 79.2 M | 79.2 M | 59 M | 59 M | 59 M | 59 M |
Book Value |
167 M | 167 M | 164 M | 167 M | 161 M | 163 M | 156 M | 160 M | 160 M | 152 M | 149 M | 147 M | 147 M | 142 M | 144 M | 150 M | 161 M | 148 M | 147 M | 141 M | 157 M | 157 M | 157 M | 157 M | 129 M | 129 M | 129 M | 129 M | 121 M | 121 M | 121 M | 121 M | 120 M | 120 M | 120 M | 120 M | 132 M | 132 M | 132 M | 132 M | 136 M | 136 M | 136 M | 136 M | 129 M | 129 M | 129 M | 129 M | 105 M | 105 M | 105 M | 200 M | 194 M | 194 M | 194 M | 194 M | 176 M | 176 M | 176 M | 176 M |
Total Shareholders Equity |
167 M | 167 M | 164 M | 167 M | 161 M | 163 M | 156 M | 160 M | 160 M | 152 M | 149 M | 147 M | 147 M | 142 M | 144 M | 150 M | 161 M | 148 M | 147 M | 141 M | 157 M | 157 M | 157 M | 157 M | 129 M | 129 M | 129 M | 129 M | 121 M | 121 M | 121 M | 121 M | 120 M | 120 M | 120 M | 120 M | 132 M | 132 M | 132 M | 132 M | 136 M | 136 M | 136 M | 136 M | 129 M | 137 M | 118 M | 115 M | 105 M | 105 M | 105 M | 105 M | 116 M | 116 M | 116 M | 116 M | 87.4 M | 87.4 M | 87.4 M | 87.4 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Nature's Sunshine Products, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Household products
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
Spectrum Brands Holdings
SPB
|
$ 88.81 | 1.58 % | $ 2.28 B |  USA |
 |
United-Guardian
UG
|
$ 7.62 | -1.8 % | $ 35 M | USA |
 |
Unilever PLC
UL
|
$ 60.94 | 1.21 % | $ 133 B |  Britain |
 |
Acme United Corporation
ACU
|
$ 53.94 | 3.97 % | $ 204 M | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.95 | -0.05 % | $ 12.7 M |  China |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
e.l.f. Beauty
ELF
|
$ 77.36 | 1.59 % | $ 4.24 B | USA |
 |
Coty
COTY
|
$ 2.65 | 1.73 % | $ 2.31 B | USA |
 |
Hims & Hers Health
HIMS
|
$ 28.09 | -14.2 % | $ 6.32 B | USA |
 |
Helen of Troy Limited
HELE
|
$ 28.47 | 6.07 % | $ 655 M |  Bermuda |
 |
Edgewell Personal Care Company
EPC
|
$ 27.63 | 3.52 % | $ 1.31 B | USA |
 |
The Clorox Company
CLX
|
$ 95.55 | 1.87 % | $ 11.8 B | USA |
 |
Church & Dwight Co.
CHD
|
$ 97.64 | 1.52 % | $ 23.7 B | USA |
 |
Newell Brands
NWL
|
$ 5.08 | 0.99 % | $ 2.12 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 109.7 | 2.23 % | $ 36.4 B | USA |
 |
Nu Skin Enterprises
NUS
|
$ 5.08 | - | $ 250 M | USA |
 |
LifeVantage Corporation
LFVN
|
$ 6.53 | 4.15 % | $ 80 M | USA |
 |
The Estée Lauder Companies
EL
|
$ 80.29 | 0.46 % | $ 28.9 B | USA |
 |
USANA Health Sciences
USNA
|
$ 21.32 | 1.91 % | $ 395 M | USA |
 |
The Procter & Gamble Company
PG
|
$ 147.41 | 1.1 % | $ 346 B | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 4.5 | -3.43 % | $ 8.55 M | USA |
 |
Colgate-Palmolive Company
CL
|
$ 90.75 | 0.74 % | $ 73.4 B | USA |
 |
Inter Parfums
IPAR
|
$ 122.55 | 2.34 % | $ 3.93 B | USA |